Valiant Navion™ VNMC4343C55TU (UDI 00763000260910)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMC4343C55TU VAL NAV CS · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 2
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000260910), received between Aug 26, 2020 and Jan 13, 2023 — classified as 2 deaths.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Recalls naming this device
- Feb 12, 2021Class IOpen, Classified
Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.
Z-1201-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Activation, Positioning or Separation Problem1
- Adverse Event Without Identified Device or Use Problem1
- Leak/Splash1
Patient problems
- Death1
- Insufficient Information1
- Intimal Dissection1
- Myocardial Infarction1
- Vascular Dissection1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
DeathJan 13, 2023Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem
VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM. IT WAS REPORTED APPROXIMATELY 6 WEEKS POST THE INDEX PROCEDURE, FOLLOW UP CT IDENTIFIED A STENT INDUCED NEW ENTRY TEAR ARISING FROM THE RIGHT LATERAL PROXIMAL END OF THE ENDOGRAFT, LEADING TO A DISSECTION FLAP EXTENDING CAUDALLY INTO THE AORTIC ROOT + AORTIC ENLARGEMENT OF THE ASCENDING THORACIC AORTA FROM 41MM TO 48MM. INTERVENTION WAS PLANNED HOWEVER THE PATIENT EXPIRED ON THIS DATE PRIOR TO THE INTERVENTION. PER THE PHYSICIAN THE CAUSE OF DEATH WAS DUE TO THE ENDOLEAK. THE CAUSE OF THE ENDOLEAK IS UNDETERMINED.
Patient problems: Insufficient Information; Myocardial Infarction; Vascular Dissection
MAUDE report 16156485 ↗DeathAug 26, 2020Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem
A VALIANT NAVION STENT GRAFT SYSTEM WAS IMPLANTED FOR THE ENDOVASCULAR TREATMENT OF A 60MM IN LENGTH THORACIC DISSECTION. IT WAS REPORTED DURING THE INDEX PROCEDURE AFTER THE STENT WAS DEPLOYED THE TIP CAPTURE COULD NOT BE RECAPTURED RESULTING IN RETROGRADE DISSECTION. PER THE PHYSICIAN THE CAUSE OF THE EVENT IS UNKNOWN. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT WILL BE MONITORED.
Patient problems: Death; Intimal Dissection
MAUDE report 10453172 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page